Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica.
β-Arrestins 1 and 2 are critical regulators of inflammation.
Endurance training is feasible in severely disabled patients with progressive multiple sclerosis.
Multiple sclerosis rehabilitation.
Several food items and multiple sclerosis: A case-control study in Ahvaz (Iran).
Time-Lapse Imaging of Glial-Axonal Interactions.
Neuropathic pain in neuromyelitis optica affects activities of daily living and quality of life.
Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica.
[Multiple sclerosis and occupational exposures: results of an explorative study].
Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls.
24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases.
A comparison of multiple patient reported outcome measures in identifying major depressive disorder in people with multiple sclerosis.
Rates of Adverse Events and Multiple Sclerosis Relapses Before and After Introduction of a Purported Generic Glatiramer Acetate in mexico: Results from a Large Patient Support Program in Mexico.
Erratum to: Association Between the Single Nucleotide Polymorphism and the Level of Aquaporin-4 Protein Expression in Han and Minority Chinese with Inflammatory Demyelinating Diseases of the Central Nervous System.
Currently Approved And Emerging Oral Therapies In Multiple Sclerosis: An Update For The Ophthalmologist.
Neuronal MHC-I expression and its implications in synaptic function, axonal regeneration and Parkinson's and other brain diseases.
Modeling the Relationship among Gray Matter Atrophy, Abnormalities in Connecting White Matter, and Cognitive Performance in Early Multiple Sclerosis.
Quality of life and patient preferences: identification of subgroups of multiple sclerosis patients.
Articulation time does not affect speeded cognitive performance in multiple sclerosis.
IL17 Mediates Pelvic Pain in Experimental Autoimmune Prostatitis (EAP).
Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability.
Apparent Diffusion Coefficient Histograms in the Follow-up of Relapsing-Remitting Multiple Sclerosis.
Systematic review of occupational therapy-related interventions for people with multiple sclerosis: part 1. Activity and participation.
Certified occupational therapy assistants.
Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.
Pages
« first
‹ previous
…
388
389
390
391
392
393
394
395
396
…
next ›
last »